Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS
GLS.WS was delisted on the 3rd of January, 2023.
Fund managers haven’t disclosed any holdings of GLS.WS yet.
GLS.WS Hedge Fund Activity: Q2 2023 in Review
0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) for Q2 2023, worth a combined $0 — down 100% from $1.79K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of GLS.WS and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $905 sold.
- 0 institutional investors held Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) as of Q2 2023, down from 4 in Q1 2023.
- Funds reported $0 of Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 positions in Q2 2023 and 4 closed out, a net change of -4 holders.
- The largest Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 seller in Q2 2023 was Radcliffe Capital Management, an estimated $905 sold.
Based on aggregated 13F filings for Q2 2023.